Literature DB >> 22500880

Concerns about the Jikei Heart Study.

Yoshiki Yui.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22500880     DOI: 10.1016/S0140-6736(12)60599-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  [Quality and integrity in the production and publication of scientific results: data trimming, manipulation and (self) plagiarism].

Authors:  T F Lüscher
Journal:  Herz       Date:  2014-08       Impact factor: 1.443

Review 2.  Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis.

Authors:  Alexandra N Nowbar; Michael Mielewczik; Maria Karavassilis; Hakim-Moulay Dehbi; Matthew J Shun-Shin; Siana Jones; James P Howard; Graham D Cole; Darrel P Francis
Journal:  BMJ       Date:  2014-04-28

Review 3.  A perspective on the benefit-risk assessment for new and emerging pharmaceuticals in Japan.

Authors:  Tetsuya Tanimoto
Journal:  Drug Des Devel Ther       Date:  2015-03-31       Impact factor: 4.162

4.  Scientific Misconduct and Social Media: Role of Twitter in the Stimulus Triggered Acquisition of Pluripotency Cells Scandal.

Authors:  Yuya Sugawara; Tetsuya Tanimoto; Shoko Miyagawa; Masayasu Murakami; Atsushi Tsuya; Atsushi Tanaka; Masahiro Kami; Hiroto Narimatsu
Journal:  J Med Internet Res       Date:  2017-02-28       Impact factor: 5.428

5.  Changes in Drug Utilization After Publication of Clinical Trials and Drug-Related Scandals in Japan: An Interrupted Time Series Analysis, 2005-2017.

Authors:  Shingo Fukuma; Tatsuyoshi Ikenoue; Yukari Yamada; Yoshiyuki Saito; Joseph Green; Takeo Nakayama; Shunichi Fukuhara
Journal:  J Epidemiol       Date:  2020-10-30       Impact factor: 3.211

Review 6.  Are Japanese randomized controlled trials up to the task? A systematic review.

Authors:  Daisuke Yoneoka; Akinori Hisashige; Erika Ota; Karin Miyamoto; Shuhei Nomura; Miwako Segawa; Stuart Gilmour; Kenji Shibuya
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

7.  Questions Surrounding iPS Cells in Japan.

Authors:  Yoshiki Yui
Journal:  Int J Stem Cells       Date:  2016-05-30       Impact factor: 2.500

8.  Doping Doctors: The Influence of the Marketing Departments of Pharmaceutical Companies on Physician and Researcher Behavior in Japan.

Authors:  Iekuni Ichikawa; Ellen Wright Clayton
Journal:  Account Res       Date:  2016       Impact factor: 2.622

9.  Concerns on a new therapy for severe heart failure using cell sheets with skeletal muscle or myocardial cells from iPS cells in Japan.

Authors:  Yoshiki Yui
Journal:  NPJ Regen Med       Date:  2018-03-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.